BioLife Solutions (BLFS) Appoints Timothy L. Moore to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors
August 25, 2022 8:03 AM EDTIndustry veteran brings extensive technical operations scale-up experience and extreme fluency in cell therapy tools and services selection process
BOTHELL, Wash., Aug. 25, 2022 /PRNewswire/ --Â BioLife Solutions, Inc. (NASDAQ: BLFS)Â ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies ("CGT") and the broader biopharma markets, today announced the appointment of Timothy L. Moore to its board of... More



